Case report reveals timely detection of Legionnaires’ disease in a pneumonia patient, improving treatment outcomes.
Diagnosing fastidious organisms like Legionella pneumophila is difficult in peripheral laboratories due to the unavailability of specialized media such as BCYE agar and the delayed results of serological tests, which are mainly epidemiological. Rapid multiplex PCR platforms, such as the BioFire® Pneumonia Panel, enable timely detection of rare pathogens including L. pneumophila. A 45-year-old female with fever, chest pain, breathlessness, and productive cough was admitted with pneumonia and sepsis. BioFire testing of a mini-BAL sample confirmed L. pneumophila. Early molecular diagnosis ensures targeted therapy, improves outcomes, and supports antimicrobial stewardship.
No takes yet. Share an insight, caveat, or question.
Rai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: